The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially landscape-changing combinations.” ...

Lung cancer disproportionately affects Black Americans, who are 16% more likely to die from the disease than white Americans.

Vaccines to treat cancers have been around since 2010, the first being approved for prostate cancer, and another in 2015 for ...

Discover insights from Summit Therapeutics' Q4 2024 earnings call, highlighting the Pfizer collaboration, ivonescimab trial expansions, and strong ...

Zongertinib, an investigational treatment for HER2-mutant advanced NSCLC, has received FDA priority review, showing positive ...

Deprivation is responsible for 78 extra cancer deaths per day in the UK according to new research by Cancer Research UK.

Summit Therapeutics (NASDAQ:SMMT) has entered a clinical trial collaboration to evaluate its cancer drug, ivonescimab, in combination with Pfizer (NYSE:PFE) antibody drug conjugates across multiple ...

Pfizer partners with Summit Therapeutics to advance cancer treatments using ADCs and ivonescimab. Click here to find out why ...

Many patients with incurable cancer aren’t getting care that could ease their suffering at the end of life, a new stud ...

A body found in an abandoned home deep in the woods in Jasper County is that of a 66-year-old man who suffered from lung ...

The American Lung Association says lung cancer is the leading cause of cancer deaths among men and women in the United States ...

Diagnosed with early-stage lung cancer, I chose robot-assisted surgery, navigating pain, fear and the bond with fellow cancer ...